Iridian Asset Management LLC Axsome Therapeutics, Inc. Transaction History
Iridian Asset Management LLC
- $275 Million
- Q2 2025
A detailed history of Iridian Asset Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 91,761 shares of AXSM stock, worth $9.66 Million. This represents 3.48% of its overall portfolio holdings.
Number of Shares
91,761
Previous 106,312
13.69%
Holding current value
$9.66 Million
Previous $12.4 Million
22.75%
% of portfolio
3.48%
Previous 4.08%
Shares
26 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$160 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$120 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...